What are the Implications of Transparency Legislation on Specialty Pharmacy?

Lanton: I think the biggest implication for transparency would be the pharmacy benefit manager itself, because right now everybody’s talking about drug costs and how high they are. Looking as a specialty provider, you don’t really have a dog in that fight. You’re kind of like a spectator because you’re watching pharma and you’re watching the insurance industry fight it out to figure out how are we going to lower those costs. In order to make sure that that argument is better, having a lot more transparency laws aimed at pharmacy benefit managers will be good in order to help specialty providers operate in a better capacity.